Výsledky vyhledávání - "Maija Vikmane"

Sinus Rhythm Maintenance After Electrical Cardioversion for Atrial Fibrillation in High-Risk Patients — Comparative Efficacy of Antiarrhythmic Medications

Autor: Kristīne Jubele, Oskars Kalējs, Maija Vikmane, Sandis Sakne, Aldis Strēlnieks, Aivars Lejnieks, Irina Pupkevica, Emma Sokolova, Inga Urtāne, Baiba Kokina

Publikováno v: Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, Vol 75, Iss 1, Pp 32-39 (2021)

Atrial fibrillation (AF) conversion to sinus rhythm by electrical cardioversion (ECV) is followed by the challenge of preventing arrhythmia recurrence, especially in high-risk patients. The properties of class IC, class III and also class II antiarrh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dac909d4893718ed735b5402a506b79
https://doi.org/10.2478/prolas-2021-0006

Zobrazit plný text záznamu

Second European Cardiac Resynchronisation Therapy Survey (Crt Survey Ii): Latvian Data Compared to Europe

Autor: Oskars Kalējs, Madara Ventiņa, Māris Blumbergs, Ginta Kamzola, Cecilia Linde, Maija Vikmane, Nikolajs Ņesterovičs, Sandis Sakne, Andrejs Ērglis, Camilla Normand, Jānis Ansabergs, Kenneth Dickstein, Aivars Lejnieks

Publikováno v: Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, Vol 74, Iss 6, Pp 358-365 (2020)

The cardiac resynchronisation therapy (CRT) survey II is a joint initiative between the European Heart Rhythm Association and the Heart Failure Association. It compiles real world data about cardiac resynchronisation therapy in European Society of Ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2297b75b1624f3bbfc7f530c55e8fbd0
https://doaj.org/article/a635a6652a8b488ab100b81136e4358d

Zobrazit plný text záznamu

Comparison of Effectiveness and Safety of Antiarrhythmic Drugs Class IC and III in Patients After Electrical Cardioversion

Autor: Maija Vikmane, Māra Karakone, Aldis Strēlnieks, Kristīne Jubele, Oskars Kalējs, Irina Pupkevica, Alberts Bērziņš, Aivars Lejnieks, Sandis Sakne

Publikováno v: Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, Vol 73, Iss 1, Pp 34-39 (2019)

Patients with atrial fibrillation are faced with an increased risk of thromboembolic events, myocardial infarction, chronic heart failure and death. For some patients with atrial fibrillation, direct current cardioversion (DCCV) is a strategy that ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0913fb7acacaadedfdd8ce290f5aef
https://doi.org/10.2478/prolas-2019-0005

Zobrazit plný text záznamu

Assessment of Factors Determining Efficacy of Cardiac Resynchronisation Therapy for Patients with Heart Failure in the Population of Latvia. Summary of the Doctoral Thesis

Autor: Maija Vikmane

The Doctoral Thesis has been elaborated at the Latvian Centre of Cardiology, Pauls Stradiņs University Hospital, Rīga. Defence: at the public session of the Doctoral Council of Medicine on 27 January 2020 at 15.00 in Hippocrates Lecture Theatre, 16

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67fef78ac49c60ffc6aacd20e40f8201
https://doi.org/10.25143/prom-rsu_2020-02_dts

Zobrazit plný text záznamu

Sirds resinhronizācijas iekārtu implantācijas efektivitātes kritēriju izvērtējums pacientiem ar sirds mazspēju Latvijas populācijā. Promocijas darba kopsavilkums

Autor: Maija Vikmane

Promocijas darbs izstrādāts Paula Stradiņa Klīniskās universitātes slimnīcas Latvijas Kardioloģijas centra Aritmoloģijas un kardiostimulācijas nodaļā. Aizstāvēsana: 2020. gada 27. janvārī plkst. 15.00 Rīgas Stradiņa universitātes M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::69c1159f356812d9af49b6922da1f6ac
https://doi.org/10.25143/prom-rsu_2020-02_pdk

Zobrazit plný text záznamu

Assessment of Factors Determining Efficacy of Cardiac Resynchronisation Therapy for Patients with Heart Failure in the Population of Latvia. Doctoral Thesis

Autor: Maija Vikmane

Promocijas darbs izstrādāts Paula Stradiņa Klīniskās universitātes slimnīcas Latvijas Kardioloģijas centra Aritmoloģijas un kardiostimulācijas nodaļā. Aizstāvēšana: 2020. gada 27. janvārī plkst. 15.00 Rīgas Stradiņa universitātes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0b48d84a8614f2daee0bf226f7f5f1
https://dspace.rsu.lv/jspui/handle/123456789/1130

Zobrazit plný text záznamu

Assessment of Cardiac Resynchronisation Therapy Efficacy Determining Factors for Patients with Moderate and Severe Heart Failure in the Population of Latvia in a 12 and 24 Month Study

Autor: Aivars Lejnieks, Maija Vikmane, Madara Ventiņa, Oskars Kalejs, Ginta Kamzola, Nikolajs Nesterovics, Dana Upite

Publikováno v: Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, Vol 72, Iss 6, Pp 313-321 (2018)

The aim of this study was to evaluate treatment of patients with moderate and severe heart failure (HF) who were resistant to pharmacotherapy in Latvia and to assess the cardiac resynchronisation therapy (CRT) by exploring the predisposing factors wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded380f525d68ef6dded2aa90ef3874d
https://doi.org/10.2478/prolas-2018-0049

Zobrazit plný text záznamu

Abstract 18105: Comparison of Efficacy and Safety of Two Dosages Dabigatran versus Warfarin in Patients with Persistent and Long-standing Atrial Fibrillation Undergoing Electrical Cardioversion

Autor: Maija Vikmane, Iveta Sime, Marina Kovalova, Andrejs Erglis, Aivars Lejnieks, Aldis Strelnieks, Sandis Sakne, Vita Saripo, Olga Litunenko, Galina Dormidontova, Milana Zabunova, Oskars Kalejs

Publikováno v: Circulation. 130

Introduction: The most important factor for efficacy and safety for patients with atrial fibrillation (AF) undergoing electrical cardioversion (ECV) is appropriate use of oral anticoagulant (OAC) therapy. Dabigatran is a possible alternative OAC ther

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc9d4ec6d1705483cabe923c40ed543a
https://doi.org/10.1161/circ.130.suppl_2.18105

Zobrazit plný text záznamu

SAFETY AND EFFICACY OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION UNDERGOING ELECTRICAL CARDIOVERSION

Autor: Marina Kovalova, Ginta Kamzola, Oskars Kalejs, Olga Litunenko, Aldis Strelnieks, Maija Vikmane, Sandis Sakne, Milana Zabunova, Aivars Lejnieks, Kaspars Kupics, Andrejs Erglis

Publikováno v: Journal of the American College of Cardiology. 63:A328

Oral anticoagulant (OAC) therapy is the most important factor for safety and efficacy for patients with atrial fibrillation (AF) undergoing electrical cardioversion (ECV). Dabigatran is a possible alternative OAC before and after ECV vs warfarin. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81542c8c7375616bbfc2e7cce1c85d3
https://doi.org/10.1016/s0735-1097(14)60328-4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání